We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IIIV:NASDAQi3 Verticals, Inc. Analysis

Data as of 2026-04-10 - not real-time

$21.69

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading just above its identified support level, with the 20‑day SMA sitting slightly ahead of the 50‑day SMA, hinting at a marginal short‑term bias. Momentum indicators are mixed: the RSI is below the neutral 50 mark, suggesting limited upside, while the MACD histogram remains in bearish territory. Volume has been on a downtrend, reinforcing the neutral price action and raising concerns about market participation. Recent price swings have produced a 30‑day volatility above 25%, indicating a fairly choppy environment for traders. The stock’s beta, just under one, points to a risk profile that tracks the broader market without excessive amplification. Investor sentiment, as captured by the Fear & Greed Index, sits in the “Extreme Greed” zone, which may be inflating demand temporarily.
On the fundamentals side, the trailing PE is dramatically higher than the industry average, flagging a substantial valuation premium. However, the forward PE compresses sharply, reflecting management’s expectation of accelerating earnings driven by a 24% growth in SaaS revenue. The balance sheet remains relatively clean, with cash exceeding debt and a modest debt‑to‑equity ratio, but free cash flow is currently flat. The company does not pay a dividend, so income‑focused investors have no yield cushion. A DCF model places intrinsic value well below the current market price, underscoring the overvalued assessment. While the business serves stable government contracts, execution risk around the SaaS transition remains a key uncertainty. Overall, the combination of high valuation, mixed technical signals, and execution risk suggests a cautious stance pending clearer earnings momentum.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price near support with bearish MACD
  • high valuation relative to peers
  • decreasing trading volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • 24% SaaS revenue growth
  • forward PE improvement
  • execution risk on SaaS transition

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • stable government contract base
  • potential for valuation compression as earnings catch up
  • moderate beta and cash‑rich balance sheet

Key Metrics & Analysis

Financial Health

Revenue Growth0.90%
Profit Margin-2.01%
P/E Ratio271.1
Debt/Equity0.95
P/B Ratio1.4
Op. Cash Flow$13.7M
Industry P/E33.9

Technical Analysis

TrendNeutral
RSI39.9
Support$21.49
Resistance$23.75
MA 20$22.48
MA 50$22.31
MA 200$27.06
MACDBearish
VolumeDecreasing
Fear & Greed Index87.27

Valuation

Fair Value$5.43
Target Price$31.33
Upside/Downside44.46%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.90
Volatility26.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.